Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.

por Missale, C., Losa, M., Boroni, F., Giovanelli, M., Balsari, A., Spano, P. F.
Publicado 1995

The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury

por Lanzillotta, A, Sarnico, I, Ingrassia, R, Boroni, F, Branca, C, Benarese, M, Faraco, G, Blasi, F, Chiarugi, A, Spano, P, Pizzi, M
Publicado 2010